HopeStage
Back to all studies
RecruitingNCT07218354

Semaglutide for risky alcohol use in Veterans

About this title

Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)

Read the official source — NCT07218354
Medication studyAges 18–80United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 80 years.

What will I do during this study?

Participants receive a semaglutide or placebo (an inactive comparison treatment) injection once a week for 24 weeks, followed by a four-week safety follow-up. The semaglutide dose starts low and is gradually increased, up to 2.4 mg per week if tolerated. The study team tracks alcohol use using calendar-based interviews.

Listed locations
Long Beach and 18 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Participation duration
24 weeks of treatment, followed by 4 weeks of safety follow-up

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: July 28, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
622
Sponsor
VA Office of Research and Development
Sponsor type
Government agency
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 80 Years
Official registry ID
NCT07218354
Official title
Show the full official title

CSP #2041 - Cessation or Reduction of Alcohol Consumption in VEterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of a GLP-1 Receptor Agonist Semaglutide in U.S. Veterans With Alcohol Use Disorder (CRAVE)

Recruitment & locations

Currently recruiting

Long Beach · Palo Alto · West Los Angeles

15 more locations
  • Orlando
  • Decatur
  • Hines
  • Ann Arbor
  • Minneapolis
  • Asheville
  • Durham
  • Cleveland
  • Portland
  • Philadelphia
  • Dallas
  • Houston
  • Salt Lake City
  • Tacoma
  • Madison

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is VA Office of Research and Development, a government agency.

Does this study involve medication?

Yes. The study involves medication, including Semaglutide and Placebo.

Who can participate?

Listed age limits: 18 years to 80 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies